IRIS
STAROPOLI, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 960
AS - Asia 663
EU - Europa 514
SA - Sud America 203
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 22
OC - Oceania 2
Totale 2.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 918
IT - Italia 309
SG - Singapore 259
BR - Brasile 155
CN - Cina 131
VN - Vietnam 93
DE - Germania 73
IN - India 52
BD - Bangladesh 40
HK - Hong Kong 40
GB - Regno Unito 31
CA - Canada 25
FI - Finlandia 20
AR - Argentina 17
NL - Olanda 16
SE - Svezia 14
RU - Federazione Russa 13
ID - Indonesia 10
MX - Messico 10
TR - Turchia 9
EC - Ecuador 8
CL - Cile 7
ES - Italia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
FR - Francia 6
ZA - Sudafrica 6
CO - Colombia 5
CR - Costa Rica 4
IQ - Iraq 4
JP - Giappone 4
PK - Pakistan 4
AT - Austria 3
KE - Kenya 3
MA - Marocco 3
PL - Polonia 3
PY - Paraguay 3
SC - Seychelles 3
EG - Egitto 2
JO - Giordania 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
KG - Kirghizistan 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 2.365
Salva come PNG Salva come JPEG
Città #
San Jose 180
Ashburn 112
Singapore 102
Dallas 73
Munich 59
Chandler 46
Santa Clara 43
Ho Chi Minh City 41
Council Bluffs 40
Hong Kong 37
Bengaluru 36
Hefei 36
Milan 35
Beijing 25
Chicago 25
London 21
New York 21
Turku 19
Hanoi 18
Catanzaro 17
Los Angeles 16
Naples 16
Phoenix 16
Rome 16
São Paulo 15
Carbonia 12
Princeton 12
Lawrence 11
The Dalles 11
Wilmington 9
Boardman 7
Ottawa 7
Parma 7
Amsterdam 6
Guangzhou 6
Haiphong 6
Montreal 6
Bologna 5
Boston 5
Buffalo 5
Charlotte 5
Orem 5
Atlanta 4
Brasília 4
Chennai 4
Da Nang 4
Ercolano 4
Melito di Porto Salvo 4
Messina 4
Olomouc 4
Porto Alegre 4
Reggio Calabria 4
Santiago 4
Shanghai 4
Tokyo 4
Afragola 3
Ankara 3
Belo Horizonte 3
Biên Hòa 3
Campina Grande 3
Carapicuíba 3
Catania 3
Curitiba 3
Florence 3
Guayaquil 3
Houston 3
Manaus 3
Moscow 3
Nairobi 3
Nuremberg 3
Redmond 3
Rio de Janeiro 3
Santo Stefano di Rogliano 3
Seattle 3
Toronto 3
Warsaw 3
Albignasego 2
Amman 2
Augusta 2
Bari 2
Barquisimeto 2
Benevento 2
Bisignano 2
Bismarck 2
Brooklyn 2
Campinas 2
Canoas 2
Cavallino 2
Columbus 2
Des Moines 2
Dhaka 2
Esslingen am Neckar 2
Figino 2
Florianópolis 2
Gatchina 2
Grimsby 2
Guarulhos 2
Jiaxing 2
Johannesburg 2
Lahore 2
Totale 1.353
Salva come PNG Salva come JPEG
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 125
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 107
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 97
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 95
Prevalence of Non-Erosive Esophageal Phenotypes in children: a European multicenter study 93
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report 90
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 89
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 85
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 83
Cardiotoxicity of anti-HER2 drugs in the treatment of metastatic breast cancer: Case report 82
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 82
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 82
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 81
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 77
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 76
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 73
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 69
Bioinformatic challenges for pharmacogenomic study: tools for genomic data analysis 67
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 65
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2− Advanced Breast Cancer Patients: An Italian Managed Access Program 61
Economic Evaluation Of A New Non-Antibiotic First-line Treatment Of Recurrent Urinary Tract Infections 60
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 60
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis 59
Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations 59
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) 58
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma 56
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 54
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 52
Frontline therapy CLL without 17p del/p53 aberrations: systematic review and Bayesian network meta-analysis 50
Ramucirumab In Gastric Cancer Treatment: An Economic Evaluation 48
First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis 41
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients. 39
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 37
Why Do You Treat pCR Patient With Pertuzumab and Trastuzumab? 35
Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper 32
Totale 2.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 0 0 17 0 2 0 9 4 8 2 2
2022/2023176 24 9 5 8 14 15 4 7 26 28 31 5
2023/2024139 44 10 12 6 7 26 1 1 0 7 13 12
2024/2025495 32 13 11 8 20 78 15 20 42 8 104 144
2025/20261.277 74 114 153 188 123 60 130 93 121 91 91 39
2026/2027251 20 81 112 38 0 0 0 0 0 0 0 0
Totale 2.419